Biodesix's Series C Round

Biodesix raised a round of funding on November 11, 2010. Investors include Qualifying Therapeutic Discovery Project.

Biodesix is a fully integrated molecular diagnostics company advancing the development of products for personalized medicine. Biodesix developed, validated and commercialized VeriStrat, a serum proteo…

Articles about Biodesix's Series C Round: